197 related articles for article (PubMed ID: 38514660)
21. Neutrophil content predicts lymphocyte depletion and anti-PD1 treatment failure in NSCLC.
Kargl J; Zhu X; Zhang H; Yang GHY; Friesen TJ; Shipley M; Maeda DY; Zebala JA; McKay-Fleisch J; Meredith G; Mashadi-Hossein A; Baik C; Pierce RH; Redman MW; Thompson JC; Albelda SM; Bolouri H; Houghton AM
JCI Insight; 2019 Dec; 4(24):. PubMed ID: 31852845
[TBL] [Abstract][Full Text] [Related]
22. Deletion of Cbl-b inhibits CD8
Kumar J; Kumar R; Kumar Singh A; Tsakem EL; Kathania M; Riese MJ; Theiss AL; Davila ML; Venuprasad K
J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33462140
[TBL] [Abstract][Full Text] [Related]
23. CD20
Wu Z; Zhou J; Xiao Y; Ming J; Zhou J; Dong F; Zhou X; Xu Z; Zhao X; Lei P; Huang T
Front Immunol; 2022; 13():865596. PubMed ID: 35634306
[TBL] [Abstract][Full Text] [Related]
24. Preventive effect of tertiary lymphoid structures on lymph node metastasis of lung adenocarcinoma.
Wakasu S; Tagawa T; Haratake N; Kinoshita F; Oku Y; Ono Y; Takenaka T; Oda Y; Shimokawa M; Mori M
Cancer Immunol Immunother; 2023 Jun; 72(6):1823-1834. PubMed ID: 36688996
[TBL] [Abstract][Full Text] [Related]
25. Tertiary lymphoid structures improve immunotherapy and survival in melanoma.
Cabrita R; Lauss M; Sanna A; Donia M; Skaarup Larsen M; Mitra S; Johansson I; Phung B; Harbst K; Vallon-Christersson J; van Schoiack A; Lövgren K; Warren S; Jirström K; Olsson H; Pietras K; Ingvar C; Isaksson K; Schadendorf D; Schmidt H; Bastholt L; Carneiro A; Wargo JA; Svane IM; Jönsson G
Nature; 2020 Jan; 577(7791):561-565. PubMed ID: 31942071
[TBL] [Abstract][Full Text] [Related]
26. CD8
Huang B; Liu R; Wang P; Yuan Z; Yang J; Xiong H; Zhang N; Huang Q; Fu X; Sun W; Li L
J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32606053
[TBL] [Abstract][Full Text] [Related]
27. Tertiary lymphoid structures as unique constructions associated with the organization, education, and function of tumor-infiltrating immunocytes.
Chen J; Chen J; Wang L
J Zhejiang Univ Sci B; 2022 Oct; 23(10):812-822. PubMed ID: 36226536
[TBL] [Abstract][Full Text] [Related]
28. Spatial Positioning of Immune Hotspots Reflects the Interplay between B and T Cells in Lung Squamous Cell Carcinoma.
Zhang H; AbdulJabbar K; Moore DA; Akarca A; Enfield KSS; Jamal-Hanjani M; Raza SEA; Veeriah S; Salgado R; McGranahan N; Le Quesne J; Swanton C; Marafioti T; Yuan Y
Cancer Res; 2023 May; 83(9):1410-1425. PubMed ID: 36853169
[TBL] [Abstract][Full Text] [Related]
29. Single-cell profiling of tumor-infiltrating TCF1/TCF7
Peng Y; Xiao L; Rong H; Ou Z; Cai T; Liu N; Li B; Zhang L; Wu F; Lan T; Lin X; Li Q; Ren S; Fan S; Li J
Oral Oncol; 2021 Aug; 119():105348. PubMed ID: 34044317
[TBL] [Abstract][Full Text] [Related]
30. Immunological potential of tertiary lymphoid structures surrounding the primary tumor in gastric cancer.
Yamakoshi Y; Tanaka H; Sakimura C; Deguchi S; Mori T; Tamura T; Toyokawa T; Muguruma K; Hirakawa K; Ohira M
Int J Oncol; 2020 Jul; 57(1):171-182. PubMed ID: 32319601
[TBL] [Abstract][Full Text] [Related]
31. Tumor-infiltrating lymphocyte subsets and tertiary lymphoid structures in pulmonary metastases from colorectal cancer.
Schweiger T; Berghoff AS; Glogner C; Glueck O; Rajky O; Traxler D; Birner P; Preusser M; Klepetko W; Hoetzenecker K
Clin Exp Metastasis; 2016 Oct; 33(7):727-39. PubMed ID: 27449756
[TBL] [Abstract][Full Text] [Related]
32. Germinal center reactions in tertiary lymphoid structures associate with neoantigen burden, humoral immunity and long-term survivorship in pancreatic cancer.
J Gunderson A; Rajamanickam V; Bui C; Bernard B; Pucilowska J; Ballesteros-Merino C; Schmidt M; McCarty K; Philips M; Piening B; Dubay C; Medler T; Newell P; Hansen P; Tran E; Tang E; Bifulco C; Crittenden M; Gough M; Young KH
Oncoimmunology; 2021 Mar; 10(1):1900635. PubMed ID: 33796412
[TBL] [Abstract][Full Text] [Related]
33. Stromal PD-L1-Positive Regulatory T cells and PD-1-Positive CD8-Positive T cells Define the Response of Different Subsets of Non-Small Cell Lung Cancer to PD-1/PD-L1 Blockade Immunotherapy.
Wu SP; Liao RQ; Tu HY; Wang WJ; Dong ZY; Huang SM; Guo WB; Gou LY; Sun HW; Zhang Q; Xie Z; Yan LX; Su J; Yang JJ; Zhong WZ; Zhang XC; Wu YL
J Thorac Oncol; 2018 Apr; 13(4):521-532. PubMed ID: 29269008
[TBL] [Abstract][Full Text] [Related]
34. Unique characteristics of tertiary lymphoid structures in kidney clear cell carcinoma: prognostic outcome and comparison with bladder cancer.
Masuda T; Tanaka N; Takamatsu K; Hakozaki K; Takahashi R; Anno T; Kufukihara R; Shojo K; Mikami S; Shinojima T; Kakimi K; Tsunoda T; Aimono E; Nishihara H; Mizuno R; Oya M
J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35314433
[TBL] [Abstract][Full Text] [Related]
35. T follicular helper cells in cancer, tertiary lymphoid structures, and beyond.
Cui C; Craft J; Joshi NS
Semin Immunol; 2023 Sep; 69():101797. PubMed ID: 37343412
[TBL] [Abstract][Full Text] [Related]
36. Single-cell profiling of infiltrating B cells and tertiary lymphoid structures in the TME of gastric adenocarcinomas.
Jia L; Wang T; Zhao Y; Zhang S; Ba T; Kuai X; Wang B; Zhang N; Zhao W; Yang Z; Qiao H
Oncoimmunology; 2021; 10(1):1969767. PubMed ID: 34513317
[TBL] [Abstract][Full Text] [Related]
37. A Subset of Localized Prostate Cancer Displays an Immunogenic Phenotype Associated with Losses of Key Tumor Suppressor Genes.
Calagua C; Ficial M; Jansen CS; Hirz T; Del Balzo L; Wilkinson S; Lake R; Ku AT; Voznesensky O; Sykes DB; Saylor PJ; Ye H; Signoretti S; Kissick H; Sowalsky AG; Balk SP; Einstein DJ
Clin Cancer Res; 2021 Sep; 27(17):4836-4847. PubMed ID: 34168052
[TBL] [Abstract][Full Text] [Related]
38. Regulatory T cells infiltrate the tumor-induced tertiary lymphoïd structures and are associated with poor clinical outcome in NSCLC.
Devi-Marulkar P; Fastenackels S; Karapentiantz P; Goc J; Germain C; Kaplon H; Knockaert S; Olive D; Panouillot M; Validire P; Damotte D; Alifano M; Murris J; Katsahian S; Lawand M; Dieu-Nosjean MC
Commun Biol; 2022 Dec; 5(1):1416. PubMed ID: 36566320
[TBL] [Abstract][Full Text] [Related]
39. CXCL13-producing CD4+ T cells accumulate in the early phase of tertiary lymphoid structures in ovarian cancer.
Ukita M; Hamanishi J; Yoshitomi H; Yamanoi K; Takamatsu S; Ueda A; Suzuki H; Hosoe Y; Furutake Y; Taki M; Abiko K; Yamaguchi K; Nakai H; Baba T; Matsumura N; Yoshizawa A; Ueno H; Mandai M
JCI Insight; 2022 Jun; 7(12):. PubMed ID: 35552285
[TBL] [Abstract][Full Text] [Related]
40. Tertiary lymphoid structures are associated with favorable survival outcomes in patients with endometrial cancer.
Qin M; Hamanishi J; Ukita M; Yamanoi K; Takamatsu S; Abiko K; Murakami R; Miyamoto T; Suzuki H; Ueda A; Hosoe Y; Horie A; Yamaguchi K; Mandai M
Cancer Immunol Immunother; 2022 Jun; 71(6):1431-1442. PubMed ID: 34689225
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]